Results of a randomized International Adjuvant Lung Cancer Trial (IALT): cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (pts) with resected non-small cell lung cancer (NSCLC)

Reviewer: Walter Sall, MD
OncoLink
Ultima Vez Modificado: 2 de junio del 2003

Translation for this article does not exist